Hanna Gerlovin
- Rheumatology top 5%
- Osteoarthritis Treatment and Mechanisms 4
- Health top 10%
- Vaccine Coverage and Hesitancy 3
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research 4
- Pharmacology top 10%
- Musculoskeletal pain and rehabilitation 3
- Inflammatory mediators and NSAID effects 3
-
- Total Knee Arthroplasty Outcomes 3
-
- Vitamin D Research Studies 3
-
- Pancreatic and Hepatic Oncology Research 3
- Co-authors
- Julie R. PalmerElena LosinaJoanne M. JordanDavid J. HunterWilliam M. ReichmannLynn RosenbergDavid GagnonKelly Cho
- Partner nations
- United StatesAustraliaIsrael
In The Last Decade
Hanna Gerlovin
28 papers receiving 772 citations
Peers
Comparison fields: 5 of 98
- Rheumatology 206
- Health 69
- Infectious Diseases 150
- Pharmacology 121
- Surgery 168
Countries citing papers authored by Hanna Gerlovin
This map shows the geographic impact of Hanna Gerlovin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanna Gerlovin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanna Gerlovin more than expected).
Fields of papers citing papers by Hanna Gerlovin
This network shows the impact of papers produced by Hanna Gerlovin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanna Gerlovin. The network helps show where Hanna Gerlovin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hanna Gerlovin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 9 | |
| 2 | 2023 | 21 | |
| 3 | 2023 | 12 | |
| 4 | 2022 | 3 | |
| 5 | 2022 | 9 | |
| 6 | 2022 | 20 | |
| 7 | 2021 | 5 | |
| 8 | 2021 | 21 | |
| 9 | 2021 | 150 | |
| 10 | 2020 | 15 | |
| 11 | 2020 | 10 | |
| 12 | 2019 | 20 | |
| 13 | 2019 | 17 | |
| 14 | 2017 | 10 | |
| 15 | 2016 | 22 | |
| 16 | 2015 | 49 | |
| 17 | 2014 | 33 | |
| 18 | 2014 | 23 | |
| 19 | 2011 | 10 | |
| 20 | 2010 | 61 |
About Hanna Gerlovin
Hanna Gerlovin is a scholar working on Health, Pharmacology and Rheumatology, having authored 29 papers that have together received 782 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (4 papers), Osteoarthritis Treatment and Mechanisms (4 papers), Vitamin D Research Studies (3 papers), Musculoskeletal pain and rehabilitation (3 papers), Pancreatic and Hepatic Oncology Research (3 papers), Vaccine Coverage and Hesitancy (3 papers), Total Knee Arthroplasty Outcomes (3 papers) and Inflammatory mediators and NSAID effects (3 papers). The work is most often cited by research in Rheumatology (206 citations), Health (69 citations) and Infectious Diseases (150 citations). Hanna Gerlovin has collaborated with scholars based in United States, Australia and Israel. Frequent co-authors include Julie R. Palmer, Elena Losina, Joanne M. Jordan, David J. Hunter, William M. Reichmann, Lynn Rosenberg, David Gagnon, Kelly Cho, A. David Paltiel and Brian R. Ferolito.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.